Autolus Therapeutics (AUTL) Times Interest Earned (2021 - 2025)
Autolus Therapeutics posted quarterly Times Interest Earned of -$3.17 for Q4 2025, down 228.98% year-on-year from $2.46 in Q4 2024, and up 53.39% on a QoQ basis from -$6.81 in Q3 2025.
Autolus Therapeutics (AUTL) has 5 years of Times Interest Earned data on file, last reported at -$3.17 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned fell 228.98% year-over-year to -$3.17; the trailing twelve-month figure through Dec 2025 stood at -$7.38 (up 71.6% YoY), and the FY2025 full-year result was -$7.38, up 71.6% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$3.17, up from -$6.81 in the prior quarter.
- Across five years, Times Interest Earned topped out at $8.96 in Q2 2025 and bottomed at -$21.58 in Q2 2022.
- The 5-year median for Times Interest Earned is -$6.43 (2025), against an average of -$7.79.
- Peak annual rise in Times Interest Earned reached 254.77% in 2025, while the deepest fall reached 228.98% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$20.85 in 2021, then surged by 83.84% to -$3.37 in 2022, then soared by 47.53% to -$1.77 in 2023, then jumped by 239.15% to $2.46 in 2024, then tumbled by 228.98% to -$3.17 in 2025.
- The last three Times Interest Earned figures came in at -$3.17 (Q4 2025), -$6.81 (Q3 2025), and $8.96 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 49.84 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 11.50 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.88 |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -3.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.17 |
| Sep 30, 2025 | -6.81 |
| Jun 30, 2025 | 8.96 |
| Mar 31, 2025 | -6.43 |
| Dec 31, 2024 | 2.46 |
| Sep 30, 2024 | -6.35 |
| Jun 30, 2024 | -5.79 |
| Mar 31, 2024 | -2.01 |
| Dec 31, 2023 | -1.77 |
| Sep 30, 2023 | -8.56 |
| Jun 30, 2023 | -8.84 |
| Mar 31, 2023 | -7.98 |
| Dec 31, 2022 | -3.37 |
| Sep 30, 2022 | -20.19 |
| Jun 30, 2022 | -21.58 |
| Mar 31, 2022 | -20.22 |
| Dec 31, 2021 | -20.85 |